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p < 0.001), adherence (0.149 and 0.17 p < 0.05), oversights
(0.13; -0.01 p > 0.05). CONCLUSIONS: A brief questionnaire
to evaluate global and speciﬁc domains related to satisfaction
with medication was developed. Further investigation is needed
to test internal consistency of adherence domain and sensitivity
to change of the SAT-Q.
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OBJECTIVES: To quantify changes in productivity within and
outside home associated with meaningful improvements in physi-
cal function or reduction of fatigue in Rheumatoid Arthritis (RA)
patients treated with certolizumab pegol, the ﬁrst PEGylated,
Fc-free anti-TNF. METHODS: Physical function and fatigue
were assessed in RAPID trials using the Health Assessment
Questionnaire-Disability Index (HAQ-DI) and the Fatigue
Assessment Scale (FAS), respectively. Clinically meaningful
improvement in HAQ-DI was 0.22 points and for FAS was
1.0 point. Productivity within and outside home was evaluated
with the RA-speciﬁc Work Productivity Survey (WPS-RA).
Improvements in productivity were compared between respond-
ers and non-responders at wk12, irrespective of treatment assign-
ment, using a non-parametric bootstrap-t method. RESULTS:
For patients employed outside home, meaningful improvement in
physical function was associated with a decrease in absenteeism;
responders gained 1.95 (p  0.05) and 0.58 (NS) additional
workdays/month compared to non-responders. Physical function
improvements were associated with a decrease in presenteeism, a
reduction of 3.26 to 4.50 workdays/month with low productivity
was observed in responders compared to non-responders (p 
0.05). Meaningful reduction in fatigue in employed patients was
related to a decrease of 2.68 (NS) to 3.37 (p  0.05) workdays/
month with low productivity compared to non-responders. For
all patients, meaningful improvement in physical function was
associated with a gain of 2.11 to 4.74 additional household
workdays/month (p  0.05) and a decrease of 1.89 to 3.40
household workdays/month with low productivity compared to
non-responders (p  0.05). Meaningful reduction in fatigue was
related to a gain of 2.41 to 3.16 additional household workdays/
month (p  0.05) and a decrease of 3.59 to 3.69 household
workdays/ month with low productivity compared to non-
responders (p  0.05). CONCLUSIONS: Meaningful reduction
in fatigue in RA patients was associated with improved produc-
tivity at home, whereas physical function improvements were
associated with increased productivity both at work and at
home.
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OBJECTIVES: Normative data were collected for the Quality of
Life Assessment of Growth Hormone Deﬁciency in Adults (QoL-
AGHDA) questionnaire in the French general population in
order to improve the QoL-AGHDA scoring system and its inter-
pretability, as well as prepare for health economic assessment.
METHODS: A postal survey was conducted on a sample of
2,900 adults belonging to TNS-Healthcare permanent polling
panel and selected to be representative of the French population.
Participants were asked to complete an 8-page questionnaire
including the QoL-AGHDA questionnaire, the EuroQoL-5
Dimension (EQ-5D), a 5-point Likert scale for the participants to
rate their overall health status (OHS) and questions about their
general and medical situation. Socio-demographic data came
from the permanent polling panel. A total score was calculated
on the 25 dichotomous items of the QoL-AGHDA questionnaire,
with a lower score indicating a better QoL. The description of the
QoL-AGHDA score was performed on weighted data in order to
ensure that the respondent population was representative of the
French population. The QoL-AGHDA score was described
according to OHS of respondents. Pearson correlation coefﬁcient
with the EQ-5D index was calculated. RESULTS: The return rate
of questionnaires was 75%; 95% of respondents completed all
QoL-AGHDA items. The mean age of the population was 50.1,
with 54.1% respondents female. The mean weighted QoL-
AGHDA score was 5.05 for women and 4.18 for men; it was
4.37 for people aged 18–40 years, 4.63 for 40–60 and 5.02 above
60. When described according to respondents’ OHS, it was: 1.54
for excellent OHS, 2.87 for very good, 4.49 for good, 7.73 for
fair and 12.30 for poor OHS. Its correlation with the EQ-5D
index was –0.59. CONCLUSIONS: Reference values for the
QoL-AGHDA questionnaire have been collected for the French
general population, completing the QoL-AGHDA normative
database already available in a number of European countries.
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OBJECTIVES: Productivity loss can be deﬁned as time missed
from work due to health reasons (absenteeism) as well as the time
of impaired performance while at work (presenteeism). This
study explored the impact of health problems on presenteeism in
patients with rheumatoid arthritis (RA) compared to a healthy
comparison group. METHODS: Patients recently diagnosed
with RA were asked to participate in this cross-sectional survey.
The comparison group was formed by subjects without RA
matched on age and sex. Presenteeism was assessed by: 1) Quan-
tity and Quality Questionnaire (QQ) reporting the quantity and
quality of the work performed on the last working day, and 2) the
Work Productivity and Activity Impairment Questionnaire
General Health (WPAI-GH) measuring the degree health prob-
lems affected work productivity on the last week. Correlation
coefﬁcients between instruments were calculated and differences
between groups were tested by Mann-Witney U tests. RESULTS:
Data were available from 78 patients of which 30 (42%) had
a paid job (mean (SD) age 47 (9); 47% female; mean (SD)
number working hours per week 30 (10)); and 87 healthy
controls of which 47 (55%) had a paid job and could be used for
analysis. Demographic characteristics as well as total working
hours per week were not signiﬁcantly different between groups.
RA patients missed more days from work due to health reasons
in the last 3 months compared to the controls (11 (22) versus
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